story of the week
Lower Risk of Heart Failure and Death in Patients Initiated on SGLT-2 Inhibitors vs Other Glucose-Lowering Drugs
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Circulation
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Lower Risk of Heart Failure and Death in Patients Initiated on SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study
Circulation 2017 May 18;[EPub Ahead of Print], M Kosiborod, MA Cavender, AZ Fu, JP Wilding, K Khunti, RW Holl, A Norhammar, KI Birkeland, M Jørgensen, M Thuresson, N Arya, J Bodegård, N Hammar, P FeniciFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.